Compile Data Set for Download or QSAR
Report error Found 87 Enz. Inhib. hit(s) with all data for entry = 12301
TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694323(US12077531, Ex. No. 72)
Affinity DataIC50: 100nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694279(US12077531, Ex. No. 27)
Affinity DataIC50: 110nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694277(US12077531, Ex. No. 25)
Affinity DataIC50: 110nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694276(US12077531, Ex. No. 24)
Affinity DataIC50: 110nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694266(US12077531, Ex. No. 13)
Affinity DataIC50: 120nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694300(US12077531, Ex. No. 49)
Affinity DataIC50: 120nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694278(US12077531, Ex. No. 26)
Affinity DataIC50: 130nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694333(US12077531, Ex. No. 82)
Affinity DataIC50: 130nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694304(US12077531, Ex. No. 53)
Affinity DataIC50: 140nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694269(US12077531, Ex. No. 16)
Affinity DataIC50: 140nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694301(US12077531, Ex. No. 50)
Affinity DataIC50: 140nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694334(US12077531, Ex. No. 83)
Affinity DataIC50: 140nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694302(US12077531, Ex. No. 51)
Affinity DataIC50: 140nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694297(US12077531, Ex. No. 46)
Affinity DataIC50: 150nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694335(US12077531, Ex. No. 84)
Affinity DataIC50: 150nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694310(US12077531, Ex. No. 59)
Affinity DataIC50: 180nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694336(US12077531, Ex. No. 85)
Affinity DataIC50: 180nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694294(US12077531, Ex. No. 43)
Affinity DataIC50: 200nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694296(US12077531, Ex. No. 45)
Affinity DataIC50: 270nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694339(US12077531, Ex. No. 88)
Affinity DataIC50: 270nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694337(US12077531, Ex. No. 86)
Affinity DataIC50: 270nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694303(US12077531, Ex. No. 52)
Affinity DataIC50: 280nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694274(US12077531, Ex. No. 22)
Affinity DataIC50: 300nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694293(US12077531, Ex. No. 42)
Affinity DataIC50: 320nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694290(US12077531, Ex. No. 39)
Affinity DataIC50: 340nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694299(US12077531, Ex. No. 48)
Affinity DataIC50: 350nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694267(US12077531, Ex. No. 14)
Affinity DataIC50: 360nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694298(US12077531, Ex. No. 47)
Affinity DataIC50: 410nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694307(US12077531, Ex. No. 56)
Affinity DataIC50: 410nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694306(US12077531, Ex. No. 55)
Affinity DataIC50: 490nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694320(US12077531, Ex. No. 69)
Affinity DataIC50: 500nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694332(US12077531, Ex. No. 81)
Affinity DataIC50: 500nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694270(US12077531, Ex. No. 17)
Affinity DataIC50: 520nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694318(US12077531, Ex. No. 67)
Affinity DataIC50: 520nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694311(US12077531, Ex. No. 60)
Affinity DataIC50: 590nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694328(US12077531, Ex. No. 77)
Affinity DataIC50: 610nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694308(US12077531, Ex. No. 57)
Affinity DataIC50: 710nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694291(US12077531, Ex. No. 40)
Affinity DataIC50: 760nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694305(US12077531, Ex. No. 54)
Affinity DataIC50: 770nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694257(US12077531, Ex. No. 2)
Affinity DataIC50: 790nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694342(US12077531, Ex. No. 91)
Affinity DataIC50: 960nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694295(US12077531, Ex. No. 44)
Affinity DataIC50: 970nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694309(US12077531, Ex. No. 58)
Affinity DataIC50: 1.02E+3nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694317(US12077531, Ex. No. 66)
Affinity DataIC50: 1.17E+3nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694321(US12077531, Ex. No. 70)
Affinity DataIC50: 1.45E+3nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694292(US12077531, Ex. No. 41)
Affinity DataIC50: 1.46E+3nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694287(US12077531, Ex. No. 36)
Affinity DataIC50: 1.51E+3nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694313(US12077531, Ex. No. 62)
Affinity DataIC50: 1.85E+3nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694325(US12077531, Ex. No. 74)
Affinity DataIC50: 1.85E+3nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetEgl nine homolog 1 [184-418](Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM694314(US12077531, Ex. No. 63)
Affinity DataIC50: 1.92E+3nMAssay Description:Human HIF-1α556-574 (FITC-labeled HIF-1α556-574), containing N-terminal FITC-Ahx, containing amino acid residues 556 to 574 (partial peptid...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

Displayed 1 to 50 (of 87 total ) | Next | Last >>
Jump to: